Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Injection for Strabismus
NCT01616108Phase 3Unknown
- Sponsor
- Smith-Kettlewell Eye Research Institute
- Start
- Apr 2012
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in strabismus, sponsored by Smith-Kettlewell Eye Research Institute. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
strabismus
Beyond the preview
Go deeper on NCT01616108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01616108.